Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primitive Neuroectodermal Tumors (PNETs)”

248 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 248 results

Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Not applicableStudy completedNCT00898053
What this trial is testing

Study of Tumor Samples From Patients With Ewing Sarcoma

Who this might be right for
Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Children's Oncology Group 200
Testing effectiveness (Phase 2)Study completedNCT00276692
What this trial is testing

Irinotecan in Treating Patients With Newly Diagnosed Ewing's Sarcoma

Who this might be right for
Sarcoma
Children's Cancer and Leukaemia Group 35
Testing effectiveness (Phase 2)Study completedNCT00070109
What this trial is testing

Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors

Who this might be right for
Previously Treated Childhood RhabdomyosarcomaRecurrent Childhood RhabdomyosarcomaRecurrent Childhood Soft Tissue Sarcoma+2 more
Children's Oncology Group 50
Testing effectiveness (Phase 2)Study completedNCT02116777
What this trial is testing

Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies

Who this might be right for
Adult Solid NeoplasmChildhood Solid NeoplasmRecurrent Childhood Central Nervous System Neoplasm+3 more
National Cancer Institute (NCI) 40
Not applicableStudy completedNCT00255671
What this trial is testing

Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerRadiation Toxicity
Case Comprehensive Cancer Center 76
Early research (Phase 1)Study completedNCT00049023
What this trial is testing

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more
O'Dorisio, M S 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT04320888
What this trial is testing

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma+35 more
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Study completedNCT02358356
What this trial is testing

Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study

Who this might be right for
Midgut Neuroendocrine TumoursPancreatic Neuroendocrine Tumours
Australasian Gastro-Intestinal Trials Group 75
Testing effectiveness (Phase 2)Ended earlyNCT00544778
What this trial is testing

Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma

Who this might be right for
Sarcoma
City of Hope Medical Center 7
Early research (Phase 1)Looking for participantsNCT02508038
What this trial is testing

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaHodgkin Lymphoma+8 more
University of Wisconsin, Madison 22
Early research (Phase 1)Study completedNCT00003597
What this trial is testing

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

Who this might be right for
Cancer
Children's Oncology Group 16
Early research (Phase 1)Ended earlyNCT00003926
What this trial is testing

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorChordoma+6 more
Masonic Cancer Center, University of Minnesota 13
Not applicableUnknownNCT00349024
What this trial is testing

Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChordomaKidney Cancer+7 more
Children's Cancer and Leukaemia Group 50
Testing effectiveness (Phase 2)Study completedNCT00003203
What this trial is testing

Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors

Who this might be right for
Brain TumorsCentral Nervous System TumorsNeuroblastoma
Children's Oncology Group 168
Testing effectiveness (Phase 2)Study completedNCT00629889
What this trial is testing

Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsSeizure
Dr Andrea Rossetti 52
Large-scale testing (Phase 3)UnknownNCT00002516
What this trial is testing

Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma

Who this might be right for
Sarcoma
University Hospital Muenster
Testing effectiveness (Phase 2)Study completedNCT01614132
What this trial is testing

Multicenter Pilot-study for the Therapy of Medulloblastoma of Adults

Who this might be right for
Medulloblastoma
University of Regensburg 33
Early research (Phase 1)Study completedNCT00946335
What this trial is testing

ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+25 more
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Study completedNCT00073983
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma

Who this might be right for
Sarcoma
Sarcoma Alliance for Research through Collaboration 54
Next Page